Haftungsausschluss: Diese Website bündelt öffentlich verfügbare Daten aus offiziellen Quellen wie FDA, ClinicalTrials.gov, PubMed und SEC EDGAR nur zur allgemeinen Information. Sie stellt keine medizinische Beratung, Diagnose, Behandlungsempfehlung oder Anlageberatung dar.

PubMed

Print Me an Organ? Ethical and Regulatory Issues Emerging from 3D Bioprinting in Medicine.

PMID: 28185142 ·

F, r, e, d, e, r, i, c, , G, i, l, b, e, r, t, ;, , C, a, t, h, a, l, , D, , O, ', C, o, n, n, e, l, l, ;, , T, a, j, a, n, k, a, , M, l, a, d, e, n, o, v, s, k, a, ;, , S, u, s, a, n, , D, o, d, d, s

ZeitschriftScience and engineering ethics
Jahr
PMID28185142

Zusammenfassung

Recent developments of three-dimensional printing of biomaterials (3D bioprinting) in medicine have been portrayed as demonstrating the potential to transform some medical treatments, including providing new responses to organ damage or organ failure. However, beyond the hype and before 3D bioprinted organs are ready to be transplanted into humans, several important ethical concerns and regulatory questions need to be addressed. This article starts by raising general ethical concerns associated

Offizielle Quelle

Auf PubMed ansehen →

Daten aus PubMed / NCBI. Den Volltext und die aktuellsten Informationen finden Sie stets im offiziellen Eintrag.

↑